Type
Internal restructuring
Country
Spain
Region
Comunidad de Madrid; Comunidad de Madrid; Madrid
Location of affected unit(s)
Sector
Health / Social work
86 - Human health activities
86.2 - Medical and dental practice activities
86.22 - Medical specialists activities

143 jobs
Number of planned job losses
Job loss
Announcement Date
3 September 2025
Employment effect (start)
3 November 2025
Foreseen end date

Description

The Swiss diagnostic company Unilabs has announced an Employment Redundancy File (ERE) in Spain that is expected to affect approximately 300 employees, around 41% of its current national workforce of 731. The company communicated the decision to employee representatives on Monday, signalling the start of a formal consultation process focused on the clinical analysis and anatomical pathology divisions.

The announcement follows recent leadership changes at Unilabs Spain. Also, Unilabs' latest financial results reveal that its operations in Spain have experienced an important revenue decline due to several factors (e.g. severe price erosion in the European healthcare market, a sharp drop in COVID-19-related testing or limited ability to offset inflation-related costs).

Update 5/112025: Unilabs Madrid has reached an agreement with employee representatives to establish compensation of 30 days’ salary per year worked, capped at 22 months, for 143 workers affected by its collective redundancy plan (ERE). The final figure represents a reduction from the 170 dismissals initially proposed. The deal, unanimously approved during negotiations, primarily impacts staff in the company’s clinical analysis and anatomical pathology laboratories in the Madrid region. The agreement also includes seven redeployment opportunities within other Unilabs facilities, each lasting 18 months under the same ERE conditions.


Sources

Citation

Eurofound (2025), Unilabs, Internal restructuring in Spain, factsheet number 203246, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/203246.